CCSC

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

Evaluation – CCSC Presents: Managing Costs and Clinical Outcomes While Preparing for a Rapidly Changing Therapeutic Landscape

Jointly provided by

Jointly provided by

    

  • CCSC is supported by charitable donations from founding supporter Takeda, and additional support from Bayer AG, Pharmaceuticals, BioMarin, bluebird bio, Inc., CSL Behring, Genentech, Inc., Hemophilia Alliance, Novo Nordisk, Inc., Pfizer, Inc., Sanofi Genzyme, and Spark Therapeutics.

    © 2021 National Hemophilia Foundation. All rights reserved.

    Staff Log In

 

Footer Menu